Back to search

Article

Peripheral blood TCRβ repertoire, IL15, IL2 and soluble ligands for NKG2D activating receptor predict efficacy of ICI in lung cancer

2024-03-05

Abstract excerpt

<title>Abstract</title> <p>The development of immune checkpoints inhibitors (ICIs) has changed the therapeutic paradigm of lung cancer (LC), becoming the standard of treatment for previously untreated advanced non-small cell lung cancer (NSCLC) without actionable mutations. It has allowed the achievement of durable responses and resulted in significant survival benefits. However, not all patients respond, hence m...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
21bad6a5-50d5-5c0a-b01f-d052684639da
DOI
10.21203/rs.3.rs-3924681/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Peripheral blood TCRβ repertoire, IL15, IL2 and soluble ligands for NKG2D activating receptor predict efficacy of ICI in lung cancerDOI 10.21203/rs.3.rs-3924681/v1
Tissue and Peripheral T-cell Repertoire Predicts Immunotherapy Response and Progression-Free Survival in NSCLC PatientsSemantic proximity
Characterization of Distinct T Cell Receptor Repertoires in Tumor and Distant Non-tumor Tissues from Lung Cancer PatientsSemantic proximity
Prognostic significance of the peripheral blood CD4/CD8 ratio in lung cancer patients: A meta-analysisSemantic proximity
Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapySemantic proximity
PD-1 upregulation enhances the immunosuppression of group 2 innate lymphoid cells by boosting IL-4 and IL-13 secretion in human non-small cell lung cancerSemantic proximity
Characteristics and prognostic significance of profiling the peripheral blood T‐cell receptor repertoire in patients with advanced lung cancerSemantic proximity
Predictive value of TCR Vβ-Jβ profile for adjuvant gefitinib in EGFR mutant NSCLC from ADJUVANT-CTONG 1104 trial.Semantic proximity
Association of Lymphocyte Subsets in Advanced Non-Small Cell Lung Cancer Patients with the Efficacy and Prognosis of Immune Checkpoint Inhibitor Therapy: A Retrospective StudySemantic proximity
Expression of LLT1 and its receptor CD161 in lung cancer is associated with better clinical outcomeSemantic proximity
Cytokine profiling identifies circulating IL-2, IL23 and sPD-L1 as prognostic biomarkers for treatment outcomes in Non-Small cell Lung Cancer patients undergoing anti-PD1 therapySemantic proximity
Enhanced circulating ILC2s and MDSCs may contribute to ensure maintenance of Th2 predominant in patients with lung cancer.Semantic proximity
Predicting immunotherapy outcomes under therapy in patients with advanced NSCLC using dNLR and its early dynamics.Semantic proximity
Select a neighboring publication to make it the new centre.